Abstract:Abstract Protocadherin-19 ( PCDH19 ) pathogenic variants cause an early-onset seizure disorder called girls clustering epilepsy (GCE). GCE is an X-chromosome disorder that affects heterozygous females and mosaic males, however hemizygous (“transmitting”) males are spared. We aimed to define the neuropsychiatric profile associated with PCDH19 pathogenic variants and determine if a clinical profile exists for transmitting males. We also examined genotype- and phenotype–phenotype associations. We developed an online PCDH19 survey comprising the following standardized assessments: The Behavior Rating Inventory of Executive Function; the Social Responsiveness Scale, 2nd edition; the Strengths and Difficulties Questionnaire; and the Dimensional Obsessive-Compulsive Scale. Genetic, seizure, and developmental information were also collected. The survey was completed by patients or by caregivers on behalf of patients. Of the 112 individuals represented (15 males), there were 70 unique variants. Thirty-five variants were novel and included a newly identified recurrent variant Ile781Asnfs*3. There were no significant differences in phenotypic outcomes between published and unpublished cases. Seizures occurred in clusters in 94% of individuals, with seizures resolving in 28% at an average age of 17.5 years. Developmental delay prior to seizure onset occurred in 18% of our cohort. Executive dysfunction and autism spectrum disorder (ASD) occurred in approximately 60% of individuals. The ASD profile included features of attention-deficit hyperactivity disorder. In addition, 21% of individuals met criteria for obsessive-compulsive disorder that appeared to be distinct from ASD. There were no phenotypic differences between heterozygous females and mosaic males. We describe a mosaic male and two hemizygous males with atypical clinical profiles. Earlier seizure onset age and increased number of seizures within a cluster were associated with more severe ASD symptoms ( p = 0.001), with seizure onset also predictive of executive dysfunction ( p = 4.69 × 10 −4 ) and prosocial behavior ( p = 0.040). No clinical profile was observed for transmitting males. This is the first patient-derived standardized assessment of the neuropsychiatric profile of GCE. These phenotypic insights will inform diagnosis, management, and prognostic and genetic counseling.

Triplication of the PCDH19 Gene as a Novel Disease Mechanism Leading to Epileptic Encephalopathy Resembling Loss-of-Function Pathogenic Variants

NGS-Based Identification of Two Novel PCDH19 Mutations in Female Patients with Early-Onset Epilepsy

De Novo Mutation in DEPDC5 Associated with Unilateral Pachygyria and Intractable Epilepsy

Prenatal diagnosis of developmental and epileptic encephalopathy 9 with a 10.05-Mb microdeletion at Xq21.31q22.1 inherited from mother: A case report and literature review

Loss-of-function Variants in DNM1 Cause a Specific Form of Developmental and Epileptic Encephalopathy Only in Biallelic State.

Mosaicism and Incomplete Penetrance of PCDH19 Mutations.

A standardized patient-centered characterization of the phenotypic spectrum of PCDH19 girls clustering epilepsy

De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy

PPP3CA gene-related developmental and epileptic encephalopathy: Expanding the electro-clinical phenotype

Dissecting the Role of PCDH19 in Clustering Epilepsy by Exploiting Patient-Specific Models of Neurogenesis

PCDH19-related epilepsy in mosaic males: The phenotypic implication of genotype and variant allele frequency

Synonymous variants in the ATP6AP2 gene may lead to developmental and epileptic encephalopathy

Novel Loss-of-Function Variants in CHD2 Cause Childhood-Onset Epileptic Encephalopathy in Chinese Patients

Phenotypes and Genotypes in Patients with SMC1A-Related Developmental and Epileptic Encephalopathy

Copy number variation analysis in 83 children with early-onset developmental and epileptic encephalopathy after targeted resequencing of a 109-epilepsy gene panel

[Developmental and epileptic encephalopathy produced by the ATP1A2 mutation]

The clinical spectrum of female epilepsy patients with PCDH19 mutations in a Chinese population

Phenotypic and genotypic characteristics of children with PCDH19 clustering epilepsy in China

Expanding the Mutational Landscape and Clinical Phenotype of CHD2-Related Encephalopathy

Leveraging multiple approaches for the detection of pathogenic deep intronic variants in developmental and epileptic encephalopathies: A case report

Neuropathology of 16p13.11 Deletion in Epilepsy